Trial Profile
A Phase 1, Open-Label Study to Evaluate the Safety and Pharmacokinetics of EXPAREL When Administered for Postsurgical Analgesia in Subjects Undergoing Posterolateral Thoracotomy
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Pacira BioSciences
- 04 Feb 2019 Status changed from recruiting to discontinued.
- 20 Jul 2018 Planned End Date changed from 30 Aug 2018 to 30 Sep 2018.
- 20 Jul 2018 Planned End Date changed from 30 Jun 2018 to 30 Aug 2018.